Literature DB >> 20440187

The price of pathology: is screening all breast reduction specimens cost effective?

Peter F Koltz1, John A Girotto.   

Abstract

Mesh:

Year:  2010        PMID: 20440187     DOI: 10.1097/PRS.0b013e3181d5139e

Source DB:  PubMed          Journal:  Plast Reconstr Surg        ISSN: 0032-1052            Impact factor:   4.730


× No keyword cloud information.
  2 in total

1.  Pathology Evaluation of Reduction Mammaplasty Specimens and Subsequent Diagnosis of Malignant Breast Disease: A Claims-Based Analysis.

Authors:  Erika D Sears; Yu-Ting Lu; Ting-Ting Chung; Adeyiza O Momoh; Kevin C Chung
Journal:  World J Surg       Date:  2019-06       Impact factor: 3.352

2.  Radiologically innocuous breast reduction specimens. Should we send them to pathology lab anyway?

Authors:  B Celik; D Senen Demiroz; M Yaz; U Muslu
Journal:  G Chir       Date:  2013 Nov-Dec
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.